Engineered extracellular vesicles antagonize SARS-CoV-2 infection by inhibiting mTOR signaling
Effective treatment approaches for patients with COVID-19 remain limited and are neither curative nor widely applicable.Activated specialized tissue effector extracellular vesicles (ASTEX) derived from genetically-enhanced skin fibroblasts, exert disease-modifying bioactivity in vivo in models of Jewelry Dish Friend Card heart and lung injury.Here